{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:05:35Z","timestamp":1778295935922,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["01C629"],"award-info":[{"award-number":["01C629"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s40618-020-01450-y","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T03:02:47Z","timestamp":1603422167000},"page":"1465-1474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Stimulated GH levels during the transition phase in Prader\u2013Willi syndrome"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-2544","authenticated-orcid":false,"given":"G.","family":"Grugni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Iughetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Licenziati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Osimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salvatoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sartorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Stagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Crin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"1450_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14:10\u201326","journal-title":"Genet Med"},{"key":"1450_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","volume":"56","author":"MG Butler","year":"2019","unstructured":"Butler MG, Hartin SN, Hossain WA, Manzardo AM, Kimonis V, Dykens E, Gold JA, Kim SJ, Weisensel N, Tamura R, Miller JL, Driscoll DJ (2019) Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study. J Med Genet 56:149\u2013153","journal-title":"J Med Genet"},{"key":"1450_CR3","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1016\/j.celrep.2018.03.018","volume":"22","author":"EG Bochukova","year":"2018","unstructured":"Bochukova EG, Lawler K, Croizier S, Keogh JM, Patel N, Strohbehn G, Lo KK, Humphrey J, Hokken-Koelega A, Damen L, Donze S, Bouret SG, Plagnol V, Farooqi IS (2018) A transcriptomic signature of the hypothalamic response to fasting and BDNF deficiency in Prader-Willi Syndrome. Cell Rep 22:3401\u20133408","journal-title":"Cell Rep"},{"key":"1450_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"Angulo MA, Butler MG, Cataletto ME (2015) Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38:1249\u20131263","journal-title":"J Endocrinol Invest"},{"key":"1450_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.beem.2016.11.003","volume":"30","author":"G Grugni","year":"2016","unstructured":"Grugni G, Marzullo P (2016) Diagnosis and treatment of GH deficiency in Prader-Willi syndrome. Best Pract Res Clin Endocrinol Metab 30:785\u2013794","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1450_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ghir.2013.09.004","volume":"23","author":"E Marostica","year":"2013","unstructured":"Marostica E, Grugni G, De Nicolao G, Marazzi N, Crin\u00f2 A, Cappa M, Sartorio A (2013) The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences. Growth Horm IGF Res 23:261\u2013266","journal-title":"Growth Horm IGF Res"},{"key":"1450_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2265.2011.04313.x","volume":"76","author":"A Corrias","year":"2012","unstructured":"Corrias A, Grugni G, Crin\u00f2 A, Di Candia S, Chiabotto P, Cogliardi A, Chiumello G, De Medici C, Spera S, Gargantini L, Iughetti L, Luce A, Mariani B, Ragusa L, Salvatoni A, Andrulli S, Mussa A, Beccaria L, Study Group for Genetic Obesity of Italian Society of Pediatric Endocrinology and Diabetology (SIEDP\/ISPED) (2012) Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome. Clin Endocrinol (Oxf) 76:843\u2013850","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cen.12694","volume":"83","author":"M Cohen","year":"2015","unstructured":"Cohen M, Harrington J, Narang I, Hamilton J (2015) Growth hormone secretion decreases with age in pediatric Prader-Willi syndrome. Clin Endocrinol (Oxf) 83:212\u2013215","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1450_CR9","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1530\/EJE-19-0298","volume":"181","author":"E Sbardella","year":"2019","unstructured":"Sbardella E, Pozza C, Isidori AM, Grossman AB (2019) ENDOCRINOLOGY AND ADOLESCENCE: Dealing with transition in young patients with pituitary disorders. Eur J Endocrinol 181:R155\u2013R171","journal-title":"Eur J Endocrinol"},{"key":"1450_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/978-0-387-33536-0_14","volume-title":"Management of Prader-Willi syndrome","author":"E Kazemi","year":"2006","unstructured":"Kazemi E, Hodapp RM (2006) Transition from adolescence to young adulthood: the special case of Prader-Willi syndrome. In: Butler MG, Lee PDK, Whitman Y (eds) Management of Prader-Willi syndrome, 3rd edn. Springer, Berlin, pp 356\u2013369","edition":"3"},{"key":"1450_CR11","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1210\/jc.2008-0649","volume":"93","author":"AP Goldstone","year":"2008","unstructured":"Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M, Speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS (2008) Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 93:4183\u20134197","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/TCRM.S70068","volume":"12","author":"G Grugni","year":"2016","unstructured":"Grugni G, Sartorio A, Crin\u00f2 A (2016) Growth hormone therapy for Prader-Willi syndrome: challenges and solutions. Ther Clin Risk Manag 12:873\u2013881","journal-title":"Ther Clin Risk Manag"},{"key":"1450_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/eje.1.01829","volume":"152","author":"PE Clayton","year":"2005","unstructured":"Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M (2005) Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 152:165\u2013170","journal-title":"Eur J Endocrinol"},{"key":"1450_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cen.13988","volume":"91","author":"SH Donze","year":"2019","unstructured":"Donze SH, Damen L, Alfen-van der Velden JAEM, Bocca G, Finken MJJ, Hoorweg-Nijman GJG, Jira PE, van Leeuwen M, Hokken-Koelega ACS (2019) Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome. Clin Endocrinol (Oxf) 91:118\u2013123","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1450_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF03344156","volume":"29","author":"E Cacciari","year":"2006","unstructured":"Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581\u2013593","journal-title":"J Endocrinol Invest"},{"key":"1450_CR16","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2013-3059","volume":"99","author":"M Bidlingmaier","year":"2014","unstructured":"Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, K\u00f6rner A, Obermayer-Pietsch B, H\u00fcbener C, Dahlgren J, Frystyk J, Pfeiffer AF, Doering A, Bielohuby M, Wallaschofski H, Arafat AM (2014) Reference intervals for insulin-like growth factor-1 (IGFI) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab 99:1712\u20131721","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/eje.1.01967","volume":"153","author":"G Corneli","year":"2005","unstructured":"Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G (2005) The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 153:257\u2013264","journal-title":"Eur J Endocrinol"},{"key":"1450_CR18","first-page":"3693","volume":"85","author":"G Aimaretti","year":"2000","unstructured":"Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E (2000) Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. J Clin Endocrinol Metab 85:3693\u20133699","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1530\/EJE-07-0384","volume":"157","author":"G Corneli","year":"2007","unstructured":"Corneli G, Di Somma C, Prodam F, Bellone J, Bellone S, Gasco V, Baldelli R, Rovere S, Schneider HJ, Gargantini L, Gastaldi R, Ghizzoni L, Valle D, Salerno M, Colao A, Bona G, Ghigo E, Maghnie M, Aimaretti G (2007) Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol 157:701\u2013708","journal-title":"Eur J Endocrinol"},{"key":"1450_CR20","first-page":"1615","volume":"83","author":"G Aimaretti","year":"1998","unstructured":"Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E (1998) Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615\u20131618","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH, Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) Guidelines for Growth Hormone and Insulin-Like Growth Factor-I treatment in children and adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr 86:361\u2013397","journal-title":"Horm Res Paediatr"},{"key":"1450_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11102-011-0372-6","volume":"15","author":"DM Cook","year":"2012","unstructured":"Cook DM, Rose SR (2012) A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary 15:301\u2013310","journal-title":"Pituitary"},{"key":"1450_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fendo.2019.00525","volume":"10","author":"G Patti","year":"2019","unstructured":"Patti G, Noli S, Capalbo D, Allegri AME, Napoli F, Cappa M, Ubertini GM, Gallizia A, Notarnicola S, Ibba A, Crocco M, Parodi S, Salerno M, Loche S, Garr\u00e9 ML, Tornari E, Maghnie M, Di Iorgi N (2019) Accuracy and limitations of the Growth Hormone (GH) Releasing Hormone-arginine retesting in young adults with childhood-onset GH deficiency. Front Endocrinol (Lausanne) 10:525","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1450_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/cen.14047","volume":"91","author":"C H\u00f6ybye","year":"2019","unstructured":"H\u00f6ybye C, Tauber M, Angulo MA, Eiholzer U, Driscoll DJ, Cassidy SB, Holland AJ (2019) Letter regarding \u201cPrevalence of growth hormone deficiency in previously GH-treated young adults with Prader-Willi syndrome\u201d by Donze et al. Clin Endocrinol (Oxf) 91:578\u2013579","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1450_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000313377","volume":"74","author":"G Diene","year":"2010","unstructured":"Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H, Tauber M, French Reference Centre for PWS (2010) Endocrine disorders in children with Prader-Willi syndrome: data from 142 children of the French database. Horm Res Paediatr 74:121\u2013128","journal-title":"Horm Res Paediatr"},{"key":"1450_CR26","doi-asserted-by":"publisher","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","volume":"98","author":"CL Deal","year":"2013","unstructured":"Deal CL, Tony M, H\u00f6ybye C, Allen DB, Tauber M, Christiansen JS, 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants (2013) Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 98:E1072-1087","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000356927","volume":"81","author":"G Di Giorgio","year":"2014","unstructured":"Di Giorgio G, Grugni G, Fintini D, Bocchini S, Spera S, Cuttini M, Cappa M, Crin\u00f2 A (2014) Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome. Horm Res Paediatr 81:189\u2013195","journal-title":"Horm Res Paediatr"},{"key":"1450_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1530\/eje.1.01873","volume":"152","author":"M Maghnie","year":"2005","unstructured":"Maghnie M, Aimaretti G, Bellone S, Bona G, Bellone J, Baldelli R, de Sanctis C, Gargantini L, Gastaldi R, Ghizzoni L, Secco A, Tinelli C, Ghigo E (2005) Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur J Endocrinol 152:589\u2013596","journal-title":"Eur J Endocrinol"},{"key":"1450_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00431-007-0555-3","volume":"167","author":"L Iughetti","year":"2008","unstructured":"Iughetti L, Bosio L, Corrias A, Gargantini L, Ragusa L, Livieri C, Predieri B, Bruzzi P, Caselli G, Grugni G (2008) Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. Eur J Pediatr 167:701\u2013702","journal-title":"Eur J Pediatr"},{"key":"1450_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000323442","volume":"75","author":"IC van Nieuwpoort","year":"2011","unstructured":"van Nieuwpoort IC, Sinnema M, Castelijns JA, Twisk JW, Curfs LM, Drent ML (2011) The GH\/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome. Horm Res Paediatr 75:403\u2013411","journal-title":"Horm Res Paediatr"},{"key":"1450_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ajmg.a.36355","volume":"164A","author":"Y Oto","year":"2014","unstructured":"Oto Y, Tanaka Y, Abe Y, Obata K, Tsuchiya T, Yoshino A, Murakami N, Nagai T (2014) Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome. Am J Med Genet A 164A:671\u2013675","journal-title":"Am J Med Genet A"},{"key":"1450_CR32","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1210\/jc.2016-2163","volume":"101","author":"M Coupaye","year":"2016","unstructured":"Coupaye M, Tauber M, Cuisset L, Laurier V, Bieth E, Lacorte JM, Oppert JM, Cl\u00e9ment K, Poitou C (2016) Effect of genotype and previous GH treatment on adiposity in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 101:4895\u20134903","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1530\/EC-18-0089","volume":"7","author":"AC Paepegaey","year":"2018","unstructured":"Paepegaey AC, Coupaye M, Jaziri A, M\u00e9nesguen F, Dubern B, Polak M, Oppert JM, Tauber M, Pinto G, Poitou C (2018) Impact of transitional care on endocrine and anthropometric parameters in Prader-Willi syndrome. Endocr Connect 7:663\u2013672","journal-title":"Endocr Connect"},{"key":"1450_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12020-011-9560-4","volume":"41","author":"R Sode-Carlsen","year":"2012","unstructured":"Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, H\u00f6ybye C (2012) Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study. Endocrine 41:191\u2013199","journal-title":"Endocrine"},{"key":"1450_CR35","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1210\/jc.2016-2594","volume":"101","author":"RJ Kuppens","year":"2016","unstructured":"Kuppens RJ, Bakker NE, Siemensma E, Tummers-de Lind van Wijngaarden RF, Donze SH, Festen DA, Alfen-van der Velden JA, Stijnen T, Hokken-Koelega AC (2016) Beneficial effects of GH in young adults with Prader-Willi Syndrome: a 2-Year crossover trial. J Clin Endocrinol Metab 101:4110\u20134116","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14274","author":"L Damen","year":"2020","unstructured":"Damen L, Grootjen LN, Donze SH, Juriaans AF, de Graaff LCG, van der Velden JAEM, Hokken-Koelega ACS (2020) Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.14274","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1450_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13023-016-0535-7","volume":"11","author":"RJ Kuppens","year":"2016","unstructured":"Kuppens RJ, Mahabier EF, Bakker NE, Siemensma EP, Donze SH, Hokken-Koelega AC (2016) Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial. Orphanet J Rare Dis 11:153","journal-title":"Orphanet J Rare Dis"},{"key":"1450_CR38","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1587\u20131609","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho KKY on behalf of the 2007 GH Deficiency Consensus Workshop Participants","year":"2007","unstructured":"Ho KKY on behalf of the 2007 GH Deficiency Consensus Workshop Participants (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695\u2013700","journal-title":"Eur J Endocrinol"},{"key":"1450_CR40","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1210\/jc.2009-0602","volume":"94","author":"A Secco","year":"2009","unstructured":"Secco A, di Iorgi N, Napoli F, Calandra E, Calcagno A, Ghezzi M, Frassinetti C, Fratangeli N, Parodi S, Benassai M, Leitner Y, Gastaldi R, Lorini R, Maghnie M, Radetti G (2009) Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing. J Clin Endocrinol Metab 94:4195\u20134204","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01367-6","author":"L Casamitjana","year":"2020","unstructured":"Casamitjana L, Gim\u00e9nez-Palop O, Corripio R, Pareja R, Berlanga E, Rigla M, Oliva JC, Caix\u00e0s A (2020) Glucagon stimulation test to assess growth hormone status in Prader-Willi syndrome. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01367-6","journal-title":"J Endocrinol Invest"},{"key":"1450_CR42","first-page":"49","volume":"6","author":"A Crin\u00f2","year":"2016","unstructured":"Crin\u00f2 A, Fintini D, Bocchini S, Carducci C, Grugni G (2016) Prader-Willi syndrome: clinical problems in transition from pediatric to adult care. Res Rep Endocr Dis 6:49\u201357","journal-title":"Res Rep Endocr Dis"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01450-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01450-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01450-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T20:17:50Z","timestamp":1634933870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01450-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01450-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"26 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol was run in accordance with the Declaration of Helsinki as revised in 2008. The study was approved by the Ethical Committee of the Istituto Auxologico Italiano (ref. no 01C629; acronym: PWStransGH).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained for all procedures from the parents or legal representatives, and from the patients when applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read and agreed to publish the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}